Nebius, Stock

Nebius Stock: A Pulled Buy Rating, $12 Billion in Fresh Contracts, and the Capex Question Investors Can't Park

Published on 11/21/2026 at 10:01 | Editorial boerse-global.de
Nebius closed at €74.15 after a 16% drop amid a broad AI sell-off, as investors weigh $12 billion in signed deals against rising capex and cash burn.
Nebius Stock: A Pulled Buy Rating, $12 Billion in Fresh Contracts, and the Capex Question Investors Can't Park Illustration mit AI erstellt.

Nebius shares closed at €74.15 on Friday after a 16% drop, caught in a sector-wide retreat that had little to do with the company's order book and everything to do with how the market is now pricing artificial-intelligence spending.

The sell-off was broad. Reuters reported a wide dump of AI-related equities as worries mounted over capital expenditure and valuations, while the Associated Press framed the same session as a sharp setback for AI names amid concern about heavy AI outlays and data-center construction. Nebius fell with the group. That distinction matters: the decline cannot be pinned solely on the more cautious research note that landed the same day.

A Buy Rating Withdrawn

That note withdrew a previously positive buy call. Its author pointed to high debt levels, pressure on free cash flow and developments at Nvidia as the reasons. The debate around Nebius, in other words, has shifted from whether demand exists to how the build-out gets paid for.

The contract flow argues that demand is real. Since the start of the quarter, Nebius has signed deals worth more than $12 billion. What those agreements do not settle is when cash actually arrives — and how the investment is funded in the meantime.

Should investors sell immediately? Or is it worth buying Nebius?

Revenue Slipping Into 2027

Company-specific trouble predates Friday's session. In its November 12 revenue outlook, Nebius blamed delays in capacity expansion by third-party providers. Some revenue originally expected in December will now slip into 2027, pushing back the point at which Nebius books that money.

For the third quarter, Nebius reported revenue of $980.8 million and adjusted earnings before interest, taxes, depreciation and amortization of $465.8 million. On the top line for the full year 2026, management expects the low end of a $3 billion to $3.4 billion range — growth, yes, but not an unambiguously strong near-term sales forecast.

The Bill Behind the Growth

Alongside those quarterly figures, Nebius raised its 2026 capital expenditure guidance to roughly $27 billion. For the following year it flagged even heavier spending: a 2027 investment plan of $40 billion to $45 billion.

That is the crux. Rising revenue and new contracts can support expansion, but with cash draining out of the business, the terms on which Nebius can raise further capital become decisive for shareholders. Growth and financial resilience have to be judged separately.

Nebius at a turning point? This analysis reveals what investors need to know now.

Burry Adds His Voice

Michael Burry weighed in on X, saying he had previously warned about Nebius among others. His comment is a critical stance, not additional evidence of a specific funding gap — but it does amplify the public argument over the company's risks.

Weighing against that skepticism is the sheer scale of the contract momentum. The open question is timing: when signed deals turn into available cash, and how the investment program is financed until they do. Until investors get a clearer answer, the gap between order growth and cash burn is likely to keep the stock sensitive to every shift in the wider AI trade.

Ad

Nebius Stock: New Analysis - 21 November

Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nebius analysis...

Disclaimer...
en | NL0009805522 | NEBIUS | boerse | 70541607 |